Literature DB >> 10526746

Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes.

K Kanková, A Vasků, D Hájek, J Záhejský, V Vasků.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10526746     DOI: 10.2337/diacare.22.10.1745b

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  6 in total

1.  Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer.

Authors:  Matúš Chocholatý; Marie Jáchymová; Marek Schmidt; Klára Havlová; Anna Křepelová; Tomáš Zima; Marko Babjuk; Marta Kalousová
Journal:  Tumour Biol       Date:  2014-11-19

Review 2.  RAGE: a novel target for drug intervention in diabetic vascular disease.

Authors:  Barry I Hudson; Ann Marie Schmidt
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

3.  Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population.

Authors:  H M Zhang; L L Chen; L Wang; Y F Liao; Z H Wu; F Ye; S Xu; L L Yi
Journal:  J Endocrinol Invest       Date:  2009-03       Impact factor: 4.256

4.  Gly82Ser polymorphism of the receptor for advanced glycation end-product (RAGE) potential high risk in patients with colorectal cancer.

Authors:  Fei Qian; Bao-lan Sun; Wen-yi Zhang; Jing Ke; Jianwei Zhu
Journal:  Tumour Biol       Date:  2013-11-19

Review 5.  Pathological Implications of Receptor for Advanced Glycation End-Product (AGER) Gene Polymorphism.

Authors:  Marine Serveaux-Dancer; Matthieu Jabaudon; Isabelle Creveaux; Corinne Belville; Raïko Blondonnet; Christelle Gross; Jean-Michel Constantin; Loïc Blanchon; Vincent Sapin
Journal:  Dis Markers       Date:  2019-02-04       Impact factor: 3.434

6.  G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology.

Authors:  Rani Cathrine C; Bincy Lukose; P Rani
Journal:  PLoS One       Date:  2020-10-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.